鱼腥草素钠对氧化镍纳米颗粒诱导大鼠肺部氧化应激损伤的保护作用OA
Protective effects of sodium houttuyfonate against nickel oxide nanoparticle-induced oxidative stress injury in rat lungs
[背景]纳米氧化镍颗粒(NiO NPs)广泛应用于工业生产,但可经呼吸道进入人体并在肺内诱发氧化应激、炎症反应及组织损伤,已成为重要的职业与环境健康风险.鱼腥草素钠(SH)具有良好的抗炎、抗氧化和免疫调节作用,且安全性较高. [目的]探讨SH对NiO NPs诱导的氧化应激和损伤的保护作用,并阐明其可能的机制. [方法]本研究采用体内外实验联合构建 NiO NPs诱导的肺损伤模型,评价 SH及其不同给药方式对氧化应激损伤的干预效应.在体外实验中,以大鼠Ⅱ型肺泡上皮细胞(ACE-II)为研究对象构建 NiO NPs染毒细胞损伤模型,测定丙二醛(MDA)、谷胱甘肽(GSH)、超氧化物歧化酶(SOD)含量,并通过实时荧光定量聚合酶链反应(qPCR)与免疫印迹法(Western blot)检测Kelch样 ECH关联蛋白 1-核因子 E2相关因子 2/血红素加氧酶-1(Keap1-Nrf2/HO-1)信号通路相关基因及蛋白表达;在体内实验中,利用 Wistar大鼠构建 NiO NPs染毒模型,采用灌胃及雾化分别给予SH及其制剂干预,并检测肺组织中上述指标的变化. [结果]NiO NPs暴露后,ACE-II细胞 GSH水平和 SOD活性显著降低,MDA水平显著升高(分别为 P<0.001、P<0.01和 P<0.001);SH干预后可升高 GSH和 SOD活性并降低 MDA水平(P<0.05).同时,NiO NPs上调 Keap1、下调 Nrf2和 HO-1的基因及蛋白表达(P<0.05),SH干预可不同程度逆转上述变化.体内实验显示,模型组大鼠肺组织 GSH和 SOD水平下降、MDA升高(P<0.05),并出现肺泡壁增宽、炎性细胞浸润及局部充血出血;SH各制剂均可提高 GSH和 SOD水平,改善肺组织病理损伤,其中纳米乳雾化组对 Keap1-Nrf2/HO-1通路相关分子的调节作用更明显(P<0.05). [结论]SH通过降低 MDA水平,提高 GSH与 SOD活性,并伴随 Keap1-Nrf2/HO-1信号通路的激活,显著缓解 NiO NPs诱导的肺部氧化应激损伤,展现出良好的抗氧化保护潜力.其纳米乳雾化剂型可提高生物利用度,为NiO NPs所致肺损伤的防治提供了新的策略与药剂学支持.
[Background]Nickel oxide nanoparticles(NiO NPs)are widely used in industrial applications and can enter the body through the respiratory tract,where they may induce oxidative stress,in-flammation,and lung tissue injury,posing a substantial occupational and environmental health risk.Sodium houttuyfonate(SH)exhibits anti-inflammatory,antioxidant,and immunomodulatory properties,alongside a favorable safety profile. [Objective]To investigate the protective effects of SH against NiO NP-induced oxidative stress and injury,and to explore the possible molecular mechanisms involved. [Methods]Both in vitro and in vivo experiments were conducted to establish NiO NP-induced lung injury models and to evaluate the effects of SH and its different formulations on oxidative stress injury.In the in vitro experiment,a NiO NP-induced injury model was established in rat alveolar type II epithelial cells(ACE-II).Malondialdehyde(MDA)levels,glutathione(GSH)levels,and superoxide dismutase(SOD)activity were measured.The gene and protein expression levels of molecules in the Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2/heme oxygenase-1(Keap1-Nrf2/HO-1)signaling pathway were detected by quantitative real-time PCR(qPCR)and Western blotting.In the in vivo experiment,a NiO NP exposure model was established in Wistar rats.SH and its formulations were administered by gavage or aerosol inhalation,and the above oxidative stress and signaling pathway indicators were examined in lung tissue. [Results]After NiO NP exposure,GSH levels and SOD activity in ACE-II cells were significantly decreased,while MDA levels were significantly increased(P<0.001,P<0.01,and P<0.001,respectively).SH intervention increased GSH levels and SOD activity and reduced MDA levels(P<0.05).NiO NPs also upregulated the mRNA and protein expression of Keap1 and downregulated the mRNA and protein expression of Nrf2 and HO-1(P<0.05),while SH treatment reversed these changes to varying degrees.In the in vivo experiment,GSH levels and SOD activity in lung tissue were decreased,whereas MDA levels were increased in the model group(P<0.05).Histopathological examination showed thickening of the alveolar wall,inflammatory cell infiltration,and focal congestion and hemorrhage.All SH formulations increased GSH levels and SOD activity and alleviated pathological lung injury.Among the tested formulations,the nanoemulsion aerosol group showed a more pronounced regulatory effect on molecules related to the Keap1-Nrf2/HO-1 pathway(P<0.05). [Conclusion]SH significantly alleviates NiO NP-induced pulmonary oxidative stress injury by reducing MDA levels,enhancing GSH levels and SOD activity,and modulating the Keap1-Nrf2/HO-1 signaling pathway.These findings suggest that SH has antioxidant protective po-tential against NiO NP-induced lung injury.The nanoemulsion aerosol formulation may enhance the bioavailability of SH,providing ex-perimental evidence for developing pharmacological strategy against NiO NP-induced pulmonary injury.
杨宗统;张梦茹;李雨霏;李晓晶;孙铁锋;刘世增;王欣如;陈晓花;王平
山东省中医药研究院中药药理研究所,山东 济南 250014||甘肃农业大学动物医学院,甘肃 兰州 730070山东省中医药研究院中药药理研究所,山东 济南 250014山东第一医科大学第一附属医院(山东省千佛山医院) 麻醉科,山东 济南 250013||山东第一医科大学第一附属医院(山东省千佛山医院) 山东省麻醉与呼吸危重症研究所,山东 济南 250013山东省中医药研究院中药药理研究所,山东 济南 250014山东省中医药研究院中药药理研究所,山东 济南 250014济宁医学院药学院,山东 日照 276826齐鲁理工学院医学院,山东 济南 250200泰安市岱岳炎黄自然国医诊所,山东 泰安 271000山东省中医药研究院中药药理研究所,山东 济南 250014
医药卫生
鱼腥草素钠纳米氧化镍氧化应激肺损伤Keap1-Nrf2/HO-1信号通路
sodium houttuyfonatenickel oxide nanoparticleoxidative stresslung injuryKeap1-Nrf2/HO-1 signaling pathway
《环境与职业医学》 2026 (7)
808-815,8
国家重点研发计划课题("政府间国际科技创新合作"重点专项)(2019YFE0117800)山东省中医药科技项目(M-2023291T)山东省技术创新引导计划(中央引导地方科技发展基金)(YDZX2024122)济南市"新高校20条"资助项目(202228121,202333006)国家中医药管理局科技项目(GZY-KJS-2023-027)山东省重点研发计划(重大科技创新工程)项目(2022CXGC020514)山东省科技型中小企业创新能力提升工程项目(2023TS-GC0043)
评论